Skip to Main Content

Paper Details

Intravenous immunoglobulin efficacy on pembrolizumab induced severe toxic epidermal necrolysis.
Anticancer Drugs
8
2022
Author NameAffiliation
Lior FuchsSoroka University Medical Center
  • 1 - 1

Datasets

Release 1.2